Eli Lilly (NYSE: LLY) director defers fees into stock units
Rhea-AI Filing Summary
Alvarez Ralph reported acquisition or exercise transactions in this Form 4 filing.
ELI LILLY & Co director Ralph Alvarez received an award of 10.8263 common shares on 2026-07-20, valued at $1146.9000 per share. At his election, the award was deferred as stock units under the Lilly Directors' Deferral Plan, to be settled in shares after separation from service. Following this grant, he holds 55734.2935 shares directly and 758.0000 shares indirectly through a trust, for which he disclaims beneficial ownership beyond his pecuniary interest. The report indicates the transaction was not made under a Rule 10b5-1 trading plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 10.8263 shares
Net Buy
2 txns
Insider
Alvarez Ralph
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1 | 10.8263 | $1,146.90 | $12K |
| holding | Common Stock F2 | -- | -- | -- |
Holdings After Transaction:
Common Stock — 55,734.2935 shares (Direct);
Common Stock — 758 shares (Indirect, By Trust)
Footnotes (2)
- F1. At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.
- F2. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Key Figures
Deferred stock units granted: 10.8263 shares
Grant valuation price: $1146.9000 per share
Direct holdings after grant: 55734.2935 shares
+1 more
4 metrics
Deferred stock units granted
10.8263 shares
Common stock award to director on 2026-07-20, deferred as stock units
Grant valuation price
$1146.9000 per share
Per-share value used for the 10.8263-share award on 2026-07-20
Direct holdings after grant
55734.2935 shares
Eli Lilly common stock held directly by Ralph Alvarez after the reported award
Indirect trust holdings
758.0000 shares
Shares held indirectly by trust, with beneficial ownership disclaimed beyond pecuniary interest
Key Terms
Lilly Directors' Deferral Plan, stock units, pecuniary interest, beneficial ownership
4 terms
Lilly Directors' Deferral Plan financial
"deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan"
stock units financial
"shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units"
Stock units are individual pieces of ownership in a company, like slices of a pie that together make up the whole business. They matter to investors because each unit represents a claim on the company’s assets, profits and sometimes voting power, and changes in the number or value of these units affect ownership percentages, potential dividends and share dilution — all of which influence an investment’s worth.
pecuniary interest financial
"disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein"
beneficial ownership financial
"The Reporting Person disclaims beneficial ownership of the reported securities except to the extent"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Eli Lilly (LLY) director Ralph Alvarez acquire in this report?
Ralph Alvarez received an award of 10.8263 Eli Lilly common shares on 2026-07-20 at $1146.9000 per share. He elected to defer this grant into stock units under the Lilly Directors' Deferral Plan, to be settled in shares after his service ends.
Are Ralph Alvarez's Eli Lilly (LLY) transactions under a Rule 10b5-1 plan?
The transaction was not reported as made under a Rule 10b5-1 trading plan. The 10b5-1 checkbox is marked negative, and no footnote states that the award or related holdings are executed pursuant to such a pre-arranged trading plan.
What is the Lilly Directors' Deferral Plan mentioned for Eli Lilly (LLY)?
The Lilly Directors' Deferral Plan lets directors elect to receive fees as stock units instead of cash. In this case, Alvarez deferred the awarded shares, which will be settled in Eli Lilly common stock after he separates from board service.